| Literature DB >> 31005866 |
Harpreet Singh1,2, Richa Handa3, Vivek Kak1, Alicja Wasilewski3.
Abstract
The interactions between opioids and gabapentin are more clinically relevant than ever. Prescriptions dispensed for gabapentin increased from 39 million in 2012 to 64 million in 2018 in the USA and are ever increasing. Authors present a challenging case of these interactions. A 58-year-old man presented to the emergency department with acute respiratory failure and altered mental status. He was on high dose opioids and gabapentin as prescription medications. Despite full intensive care support and resolution of his respiratory failure with non-invasive positive pressure ventilation, the patient did not regained consciousness. After ruling out other causes, the diagnosis of gabapentin withdrawal was considered. Gabapentin was administered by a nasogastric tube that quickly resulted in a reversal of his symptoms. We concluded that severe gabapentin withdrawal should be considered in patients on higher doses of gabapentin when it is stopped abruptly. In such patients, gabapentin should be replaced. As most patients are unable to swallow in this situation and intravenous formulation is not available, nasogastric tube can be used for replacement. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: adult intensive care; drug interactions; drugs and medicines; drugs: cns (not psychiatric)
Mesh:
Substances:
Year: 2019 PMID: 31005866 PMCID: PMC6506108 DOI: 10.1136/bcr-2018-228354
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X